Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Summary

This phase II trial studies how well bortezomib works in treating patients with newly diagnosed multiple myeloma. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2004-01

Primary completion

2012-10

Completion

2012-10

Drugs

Indications